Literature DB >> 16813109

Large cell neuroendocrine thymic carcinoma coexisting within large WHO type AB thymoma.

Yoko Nagata1, Kiyoshi Ohno, Tomoki Utsumi, Yoshiaki Sasaki, Yuko Suzuki.   

Abstract

Large cell neuroendocrine carcinoma (LCNEC) is a rare type of thymic epithelial tumor. It is recognized as a different entity from other thymic tumors on account of it having a more aggressive biologic behavior and poor prognosis. We report an extremely rare case of a very small, "large cell neuroendocrine thymic carcinoma" coexisting within a large thymoma that could not be detected by usual biopsy. Surgery as the initial treatment has the significance of definitive diagnosis and curative treatment for LCNEC of the thymus. To make a successful differential diagnosis, application of detailed immunohistochemical stains may be of aid, since thymic epithelial tumor is not always morphologically homogenous.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16813109     DOI: 10.1007/pl00022248

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  7 in total

1.  Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases.

Authors:  C A Moran; S Suster
Journal:  Am J Clin Pathol       Date:  2000-07       Impact factor: 2.493

2.  Large cell neuroendocrine carcinoma of the thymus.

Authors:  R Chetty; S Batitang; D Govender
Journal:  Histopathology       Date:  1997-09       Impact factor: 5.087

3.  Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.

Authors:  W D Travis; R I Linnoila; M G Tsokos; C L Hitchcock; G B Cutler; L Nieman; G Chrousos; H Pass; J Doppman
Journal:  Am J Surg Pathol       Date:  1991-06       Impact factor: 6.394

4.  A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus.

Authors:  Olivier Tiffet; Andrew G Nicholson; Georges Ladas; Mary N Sheppard; Peter Goldstraw
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

5.  Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.

Authors:  T T Kuo; J K Chan
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

6.  Follow-up study of thymomas with special reference to their clinical stages.

Authors:  A Masaoka; Y Monden; K Nakahara; T Tanioka
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

7.  Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases.

Authors:  Kazuhiko Ogawa; Takafumi Toita; Takashi Uno; Nobukazu Fuwa; Yasumasa Kakinohana; Minoru Kamata; Kageharu Koja; Takao Kinjo; Genki Adachi; Sadayuki Murayama
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

  7 in total
  5 in total

1.  Large-cell neuroendocrine carcinoma in the thymus.

Authors:  Seiji Mega; Mitsuru Oguri; Ryosuke Kawasaki; Kazuaki Hazama; Kazuhiro Iwai; Satoshi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-11-12

2.  Resected thymic large cell neuroendocrine carcinoma: report of a case.

Authors:  Hiromitsu Domen; Yasuhiro Hida; Masaaki Sato; Haruka Takahashi; Tatsuru Ishikawa; Yosuke Shionoya; Midori Hashimoto; Kaoru Nishiyama; Yuma Aoki; Kazuho Inoko; Syotaro Furukawa; Kazuomi Ichinokawa; Hidehisa Yamada
Journal:  Surg Case Rep       Date:  2018-11-16

3.  Resected thymic large cell neuroendocrine carcinoma: A case report and review of the literature.

Authors:  Shogo Ogata; Ryo Maeda; Masaki Tomita; Yuichiro Sato; Takanori Ayabe; Kunihide Nakamura
Journal:  Int J Surg Case Rep       Date:  2019-06-08

Review 4.  Recent advances and conceptual changes in the classification of neuroendocrine tumors of the thymus.

Authors:  Hanibal Bohnenberger; Philipp Ströbel
Journal:  Virchows Arch       Date:  2021-02-08       Impact factor: 4.064

5.  Large Cell Neuroendocrine Carcinoma of the Mediastinum Successfully Treated with Systemic Chemotherapy after Palliative Radiotherapy.

Authors:  Takeaki Hidaka; Saki Okuzumi; Ako Matsuhashi; Hidenori Takahashi; Kazunori Hata; Seiichiro Shimizu; Yoshinobu Iwasaki
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.